Oakbrook Investments’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,450
| Closed | -$481K | – | 566 |
|
|
2019
Q4 | $481K | Sell |
4,450
-6,175
| -58% | -$660K | 0.1% | 343 |
|
|
2019
Q3 | $1.04M | Sell |
10,625
-1,600
| -13% | -$180K | 0.07% | 228 |
|
|
2019
Q2 | $1.6M | Buy |
+12,225
| New | +$1.58M | 0.1% | 167 |
|
|
2018
Q3 | – | Sell |
-17,980
| Closed | -$2.23M | – | 694 |
|
|
2018
Q2 | $2.23M | Buy |
+17,980
| New | +$2.1M | 0.14% | 114 |
|
|
2018
Q1 | – | Sell |
-16,850
| Closed | -$2.02M | – | 629 |
|
|
2017
Q4 | $2.02M | Buy |
16,850
+375
| +2% | +$45.7K | 0.13% | 120 |
|
|
2017
Q3 | $2.31M | Sell |
16,475
-275
| -2% | -$37.4K | 0.15% | 125 |
|
|
2017
Q2 | $2.04M | Sell |
16,750
-1,625
| -9% | -$189K | 0.14% | 132 |
|
|
2017
Q1 | $2.23M | Buy |
18,375
+8,250
| +81% | +$1.06M | 0.15% | 126 |
|
|
2016
Q4 | $1.24M | Buy |
+10,125
| New | +$1.24M | 0.08% | 192 |
|
|
2016
Q1 | – | Sell |
-12,739
| Closed | -$2.43M | – | 575 |
|
|
2015
Q4 | $2.43M | Sell |
12,739
-825
| -6% | -$144K | 0.16% | 119 |
|
|
2015
Q3 | $2.12M | Hold |
13,564
| – | – | 0.14% | 142 |
|
|
2015
Q2 | $2.45M | Sell |
13,564
-12,700
| -48% | -$2.19M | 0.15% | 138 |
|
|
2015
Q1 | $4.55M | Buy |
26,264
+11,425
| +77% | +$2.07M | 0.25% | 92 |
|
|
2014
Q4 | $2.75M | Sell |
14,839
-875
| -6% | -$162K | 0.15% | 140 |
|
|
2014
Q3 | $2.61M | Sell |
15,714
-15,725
| -50% | -$2.58M | 0.14% | 149 |
|
|
2014
Q2 | $4.91M | Buy |
31,439
+575
| +2% | +$90.8K | 0.15% | 159 |
|
|
2014
Q1 | $4.7M | Sell |
30,864
-38,450
| -55% | -$6.11M | 0.15% | 161 |
|
|
2013
Q4 | $9.21M | Sell |
69,314
-3,961
| -5% | -$475K | 0.26% | 107 |
|
|
2013
Q3 | $8.51M | Buy |
+73,275
| New | +$8.04M | 0.25% | 103 |
|
Other funds holding ALXN
BBA
